Insmed reported $1.36M in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
DBV Technologies DBVT:US USD 10.72M 11K
Acelrx Pharmaceuticals ACRX:US USD 7K 140K
Alimera Sciences ALIM:US USD 70K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Cytokinetics CYTK:US USD 94K 1000
Dynavax Technologies DVAX:US USD 128K 1000
Heron Therapeutics HRTX:US USD 1.19M 163K
Insmed INSM:US USD 1.36M 140K
Mirati Therapeutics MRTX:US USD 58K 0
Novartis NVS:US USD 890M 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 2K
Ultragenyx Pharmaceutical RARE:US USD 70K 0